Teplizumab approval for type 1 diabetes in the USA

Overview publication

TitleTeplizumab approval for type 1 diabetes in the USA
DateFebruary 1st, 2023
Issue nameThe Lancet Diabetes & Endocrinology
Issue numberv11.2 p78-80
DOI10.1016/s2213-8587(22)00384-9
AuthorsBeran D, Abidha C, Adler A, de Beaufort C, Lepeska M, Levitt N, Pfiester E, Zafra-Tanaka JH & Gale EA
MTGsMTG3
Read Read publication